beta-lactams has been researched along with Febrile Neutropenia in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 7 (38.89) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Guo, S; Li, Y; Liang, X; Su, H; Tan, X; Xi, J | 1 |
| Alegria, W; Bixby, DL; Gregg, KS; Marini, BL; Nagel, J; Perissinotti, A | 1 |
| Chinea, A; Chumbita, M; Cuesta, MA; Español Morales, I; Fernández Abellán, P; Garcia-Vidal, C; González-Sierra, P; Gudiol, C; Guerreiro, M; Lopera, C; Monzó, P; Puerta-Alcalde, P; Rojas, R; Sánchez Pina, JM; Sánchez Vadillo, I; Varela, R; Vázquez, L; Yáñez, L | 1 |
| Crawford, R; Hobbs, ALV; Hobbs, DA; Perkins, NB | 1 |
| Albasanz-Puig, A; Arnan, M; Batlle, M; Carmona-Torre, F; Carratalà, J; Del Pozo, JL; Garcia-Vidal, C; Gudiol, C; Huguet, M; Laporte-Amargos, J; Muñoz, C; Padullés, A; Parody, R; Puerta-Alcalde, P; Rigo-Bonnin, R; Sureda, A; Tebé, C; Tubau, F; Videla, S | 1 |
| Chen, L; Jiang, J; Li, X; Li, Y; Liang, X; Tang, X | 1 |
| Blumenthal, KG; Fu, X; Mancini, CM; Naureckas Li, C; Zhang, Y | 1 |
| Horita, N; Kaneko, T; Namkoong, H; Shibata, Y; Watanabe, H | 3 |
| Click, Z; Geswein, L; Varughese, C | 1 |
| Amit, O; Avivi, I; Ben-Ami, R; Halavy, Y; Katchman, E; Kor, S; Paran, Y; Ram, R; Yachini, B | 1 |
| Ben-Ami, R; Ram, R | 1 |
| Albasanz-Puig, A; Carratalà, J; Cuervo, G; Gudiol, C; Laporte, J; Sánchez-Ortega, I | 1 |
| Fantin, B; Goulenok, T | 1 |
| Jensen, LH; Johansson, S | 1 |
| Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Ohtake, S; Sakagami, M; Takahashi, H; Takei, M; Uchino, Y | 1 |
| Contreras, V; Heredia, A; Sepúlveda, S | 1 |
6 review(s) available for beta-lactams and Febrile Neutropenia
| Article | Year |
|---|---|
Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Child; Drug Therapy, Combination; Febrile Neutropenia; Female; Humans; Imipenem; Male; Meropenem; Network Meta-Analysis; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Therapy, Combination; Febrile Neutropenia; Humans; Randomized Controlled Trials as Topic | 2020 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug-Related Side Effects and Adverse Reactions; Febrile Neutropenia; Humans; Neoplasms; Survival Analysis; Treatment Outcome | 2017 |
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Febrile Neutropenia; Fluoroquinolones; Glycopeptides; Humans | 2013 |
[Fast identification of febrile neutropenia improves the outcome].
Topics: Anti-Bacterial Agents; beta-Lactams; Early Diagnosis; Febrile Neutropenia; Humans; Treatment Outcome | 2015 |
Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Databases, Factual; Drug Therapy, Combination; Febrile Neutropenia; Humans; Neoplasms; Randomized Controlled Trials as Topic | 2016 |
3 trial(s) available for beta-lactams and Febrile Neutropenia
| Article | Year |
|---|---|
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Clinical Trials, Phase IV as Topic; Critical Care; Critical Illness; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infusions, Parenteral; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Spain; Treatment Outcome; Young Adult | 2020 |
Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Febrile Neutropenia; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2018 |
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome | 2016 |
9 other study(ies) available for beta-lactams and Febrile Neutropenia
| Article | Year |
|---|---|
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute | 2022 |
Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Febrile Neutropenia; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Retrospective Studies; Sepsis; Spain | 2022 |
Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Retrospective Studies | 2022 |
Association of beta-lactam allergy documentation and antibiotic use in patients with febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Hypersensitivity; Febrile Neutropenia; Humans; Meropenem; Penicillins | 2021 |
Comparison of antipseudomonal beta-lactams for febrile neutropenia empiric therapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans | 2018 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: authors' response.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans | 2018 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis: authors' reply.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans; Neoplasms; Network Meta-Analysis | 2018 |
Reply to Gudiol et al.
Topics: beta-Lactams; Febrile Neutropenia; Humans | 2019 |
Extended Infusion of Broad-spectrum β-Lactams in High-risk Febrile Neutropenic Patients.
Topics: beta-Lactams; Febrile Neutropenia; Fever; Humans | 2019 |